<img class="lazy" src="data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%201%201'%3E%3C/svg%3E" data-src="https://cdn.cancerletter.com/media/2021/03/17053004/TCL-logo-horizontal-white.png" alt="" >

The Cancer Letter

Surveillance Treatment Option For Low-Risk Prostate Cancer

Toxicity, Non-Cancer Deaths Increase With Combo Therapy

Time Spent Sitting Associated With Total Mortality, Study Finds

Cancer Mortality Rate Down 1.3 Percent, ACS Report Finds

NCI-Approved Clinical Trials

By Defending Potti, Duke Officials Become Target Of Charges Of Institutional Failure

Duke Officials Decline To Provide Details Of Probe

Biostatisticians Write To Varmus Asking NCI To Investigate

The Lancet Oncology Issues “Expression Of Concern” Over Paper

Duke Insiders Allege Intimidation By Administration